Prestige Consumer Healthcare (PBH) Long-Term Deferred Tax (2018)

Prestige Consumer Healthcare (PBH) recorded quarterly Long-Term Deferred Tax of $26000.0 in Q1 2018.

Prestige Consumer Healthcare (PBH) Long-Term Deferred Tax (2018) Analysis & Trends

Prestige Consumer Healthcare's Long-Term Deferred Tax history runs 1 years deep, the most recent figure standing at $26000.0 for Q1 2018.

In Q1 2018, Long-Term Deferred Tax changed N/A year-over-year to $26000.0; the TTM figure through Mar 2018 stood at $26000.0 (changed N/A YoY), while the FY2018 annual figure was $26000.0, changed N/A from the prior year.
Long-Term Deferred Tax was $26000.0 for Q1 2018 at Prestige Consumer Healthcare.
In the past five years, Long-Term Deferred Tax ranged from a high of $26000.0 in Q1 2018 to a low of $26000.0 in Q1 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Teva Pharmaceutical Industries	39.72 Bn	35.98 Bn	1.97 Bn
2	Zoetis	34.61 Bn	32.67 Bn	1.62 Bn
3	United Therapeutics	24.07 Bn	21.91 Bn	648.10 Mn
4	Aurora Cannabis	16.98 Bn	16.91 Bn	33.43 Mn
5	Neurocrine Biosciences	16.64 Bn	15.32 Bn	800.70 Mn
6	Elanco Animal Health	12.19 Bn	11.76 Bn	785.00 Mn
7	Alkermes	7.37 Bn	6.86 Bn	-116.06 Mn
8	Hims & Hers Health	6.62 Bn	5.87 Bn	396.79 Mn
9	Lantheus Holdings	6.47 Bn	5.97 Bn	230.92 Mn
10	Prestige Consumer Healthcare	2.37 Bn	2.31 Bn	157.37 Mn

Download Data

Date	Value
Mar 31, 2018	26,000.00